Loading clinical trials...
Loading clinical trials...
Treatment of Non-small Cell Lung Cancer With CIK Cells Blocked by PD-1 Antibody
Conditions
Interventions
CIK cells with PD-1 blocking
standard lung cancer treament
+1 more
Start Date
January 1, 2018
Primary Completion Date
January 1, 2023
Completion Date
January 1, 2023
Last Updated
September 14, 2017
NCT06305754
NCT07190248
NCT07100080
NCT07195695
NCT06357533
NCT06731413
Lead Sponsor
Dalian University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions